Symbiotec Pharmalab
India
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (3)
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
○ MHRA GMP
✓ HC GMP (8)
Quick Facts: Symbiotec Pharmalab
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- India
- Website
- https://www.symbiotec.com/
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Symbiotec Pharmalab
Symbiotec Pharmalab makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 2 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.symbiotec.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Symbiotec Pharmalab FDA Inspection History
2026-08
2026-04
2022-09
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-08-14 |
Symbiotec Pharmalab Limited
Pithampur, Dhar
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2026-04-03 |
Symbiotec Pharmalab Limited
Mhow
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2022-09-30 |
Symbiotec Pharmalab Limited
Pithampur, Dhar
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 2 articles
Company announcements, not verified evidence. They do not change any score.
Symbiotec Pharmalab Gets Motilal Oswal's 'Buy' Initiation; Check Target Price - NDTV Profit
Symbiotec Pharmalab Gets Motilal Oswal's 'Buy' Initiation; Check Target Price NDTV Profit
Buy Symbiotec Pharmalab; target of Rs 1430: Motilal Oswal - Moneycontrol.com
Buy Symbiotec Pharmalab; target of Rs 1430: Motilal Oswal Moneycontrol.com
Frequently Asked Questions About Symbiotec Pharmalab
How many FDA inspections does Symbiotec Pharmalab have on record?
CDMO Signal tracks 3 FDA inspections for Symbiotec Pharmalab, sourced from the FDA inspection database. See the full inspection history above.
Has Symbiotec Pharmalab received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Symbiotec Pharmalab.
Does Symbiotec Pharmalab have a CDMO Signal Score?
Not yet. Symbiotec Pharmalab is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Symbiotec Pharmalab for a manufacturing program?
Use the free AI matchmaker to compare Symbiotec Pharmalab against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Sai Life Sciences
India
Small Molecule API
Coral Drugs
India
Small Molecule API
Aarti Pharmalabs
India
Small Molecule API
Anthem Biosciences
India
Small Molecule API, Peptides & Oligos, Biologics
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Compare Symbiotec Pharmalab with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.